Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products.

RATIONALE Mechano growth factor (MGF) is a splice variant of insulin-like growth factor that possesses anabolic properties and has not yet been approved for therapeutic use. Nevertheless, it is readily available on the black market. Although the World Anti-Doping Agency (WADA) has banned the use of MGF in sports, no routinely performed methods have been reported for its detection. In this work, two preparations from the black market containing an unknown MGF analogue were characterized. METHODS Mass spectrometry characterizations of unknown preparations and a reference human MGF were performed on an Orbitrap and a triple quadrupole mass spectrometers after separation by liquid chromatography. High accuracy measurements allowed protein identification from full scan MS data, and low-resolution full scan MS/MS provided further information on fragmentation. RESULTS HCD scans of the analytes showed the presence of common b series product ions in the black market preparations and the human MGF reference standard, but all the y series ions starting from (y(1))(+) exhibited a difference of 1 m/z unit in nominal mass. This difference was demonstrated to be due to a C-terminal amidation of MGF. High-resolution data demonstrated that the black market products were both C-terminal amidated analogues of human MGF. In addition, low-resolution MS/MS characterization revealed a potentially diagnostic transition (m/z 717.8 → 431.1) for the discrimination of C-amidated MGF from the endogenous form. CONCLUSIONS Qualitative identification of a MGF C-terminal amidated analogue in two black market products was successfully achieved. This report demonstrates that illegal MGF preparations are commercially available for use as doping agent in sports.

[1]  G. Goldspink,et al.  Different roles of the IGF‐I Ec peptide (MGF) and mature IGF‐I in myoblast proliferation and differentiation , 2002, FEBS letters.

[2]  R W Orrell,et al.  Expression of IGF‐I splice variants in young and old human skeletal muscle after high resistance exercise , 2003, The Journal of physiology.

[3]  Shuichi Machida,et al.  Regrowth of skeletal muscle atrophied from inactivity. , 2004, Medicine and science in sports and exercise.

[4]  M. Thevis,et al.  Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[5]  M. Thevis,et al.  Detection of His-tagged Long-R³-IGF-I in a black market product. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[6]  G. Goldspink,et al.  Growth factors, muscle function, and doping. , 2010, Endocrinology and metabolism clinics of North America.

[7]  P. Hemmersbach,et al.  Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.

[8]  K. Matthews,et al.  Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. , 2008, Heart, lung & circulation.

[9]  M. Thevis,et al.  Nutritional supplements cross-contaminated and faked with doping substances. , 2008, Journal of mass spectrometry : JMS.

[10]  Ó. Pozo,et al.  Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry. , 2008, Analytical chemistry.

[11]  A. Bernkop‐Schnürch,et al.  Strategies to improve plasma half life time of peptide and protein drugs , 2006, Amino Acids.

[12]  G. Goldspink Research on Mechano Growth Factor: Its Potential for Optimising Physical Training as Well as Misuse in Doping Cloning of Mgf and Other Human Muscle Igf-i Splice Variants , 2022 .

[13]  A. Sarnowska,et al.  A strong neuroprotective effect of the autonomous C‐terminal peptide of IGF‐1 Ec (MGF) in brain ischemia , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  G. Goldspink,et al.  Growth factors and muscle ageing , 2004, Experimental Gerontology.

[15]  M. Thevis,et al.  Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. , 2010, Drug testing and analysis.

[16]  K. Deventer,et al.  Detection of selected stimulants as contaminants in solid nutritional supplements by liquid chromatography–mass spectrometry , 2007 .

[17]  Richard W. Orrell,et al.  Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment] , 2003 .

[18]  F. Delbeke,et al.  Validation of a GC-MS screening method for anabolizing agents in aqueous nutritional supplements. , 2005, Journal of chromatographic science.

[19]  M. Thevis,et al.  Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. , 2010, Drug testing and analysis.

[20]  Shahram Mohaghegh,et al.  Doping and the Latest Prohibited List of the World Anti-Doping Agency (WADA) , 2013 .

[21]  T. Randolph,et al.  Phase separation of excipients during lyophilization: effects on protein stability. , 1997, Journal of pharmaceutical sciences.